Periscope Capital’s Inception Growth Acquisition Limited Warrants IGTAW Stock Holding History

Periscope Capital’s Portfolio IGTAW Stock Details IGTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-59,400	Closed	-$3.59K	–	251
2024 Q3	$3.59K	Hold	59,400	–	–	﹤0.01%	230
2024 Q2	$3.87K	Sell	59,400 -42,500	-42%	-$3.93K	﹤0.01%	296
2024 Q1	$4.08K	Hold	101,900	–	–	﹤0.01%	383
2023 Q4	$1.78K	Hold	101,900	–	–	﹤0.01%	468
2023 Q3	$10.2K	Hold	101,900	–	–	﹤0.01%	530
2023 Q2	$4.2K	Hold	101,900	–	–	﹤0.01%	664
2023 Q1	$2.55K	Hold	101,900	–	–	﹤0.01%	778
2022 Q4	$3.33K	Hold	101,900	–	–	﹤0.01%	861
2022 Q3	$7K	Hold	101,900	–	–	﹤0.01%	1044
2022 Q2	$12K	Hold	101,900	–	–	﹤0.01%	1066
2022 Q1	$23K	Buy	+101,900	New	+$19.8K	﹤0.01%	1097

Other funds holding IGTAW

CCM

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Periscope Capital's IGTAW Position: Q4 2024 in Review

Periscope Capital sold out of Inception Growth Acquisition Limited Warrants (IGTAW) in Q4 2024, closing a stake of 59,400 shares — an estimated $3.59K sold.

Periscope Capital first reported a position in IGTAW in Q1 2022 and held it in 11 quarters. The position peaked at $23K in Q1 2022. 3 funds tracked by Wall St. Rank hold IGTAW as of Q4 2024.

Periscope Capital reported no remaining Inception Growth Acquisition Limited Warrants position as of Q4 2024 after selling out during the quarter.
Periscope Capital sold 59,400 Inception Growth Acquisition Limited Warrants shares in Q4 2024, an estimated $3.59K.
Periscope Capital first reported a position in Inception Growth Acquisition Limited Warrants in Q1 2022 and held it in 11 quarters.
Periscope Capital's Inception Growth Acquisition Limited Warrants position peaked at $23K in Q1 2022.
3 funds tracked by Wall St. Rank held Inception Growth Acquisition Limited Warrants as of Q4 2024.

Based on Periscope Capital's 13F filing for Q4 2024, filed 10 Feb 2025.